Home Clinical Topics FDA approves new drug for osteoporosis

FDA approves new drug for osteoporosis

On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who are at high risk of fractures.

Read more here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here